Abstract
No public abstract is available from the verified source records.
Kazumasa Ikeda, Kazuya Takihara, Kosei Terada
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
10.1016/j.jacc.2021.09.006 · 2022
2024 ESC guidelines for the management of chronic coronary syndromes
10.1093/eurheartj/ehae177 · 2024
Measurement of hyperemic pullback pressure gradients to characterize patterns of coronary atherosclerosis
10.1016/j.jacc.2019.07.072 · 2019
Feasibility of quantitative flow ratio-derived pullback pressure gradient index and its impact on diagnostic performance
10.1016/j.jcin.2020.10.036 · 2021
Influence of pathophysiologic patterns of coronary artery disease on immediate percutaneous coronary intervention outcomes
10.1161/circulationaha.124.069450 · 2024
Impact of pullback pressure gradient on clinical outcomes after percutaneous coronary interventions
10.1161/circinterventions.125.016022 · 2025
Influence of pullback pressure gradient on residual angina at one year
10.1161/circinterventions.125.015851 · 2026
Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries
10.1016/j.amjcard.2005.09.084 · 2006
Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses
10.1016/j.ijcard.2012.01.080 · 2013
Physiological patterns of coronary artery disease and drug-coated balloon performance
10.1016/j.jacasi.2026.06.043 · 2026
Angiographic and functional assessment after paclitaxel or sirolimus drug-coated balloons for de novo coronary artery disease in small vessels: PICCOLETO VI study
10.4244/aij-d-25-00057 · 2026
Physiological distribution and local severity of coronary artery disease and outcomes after percutaneous coronary intervention
10.1016/j.jcin.2021.06.013 · 2021
Coronary atherosclerosis phenotypes in focal and diffuse disease
10.1016/j.jcmg.2023.05.018 · 2023
Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions
10.1161/01.cir.91.7.1959 · 1995
The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease
10.1016/j.jcin.2013.07.005 · 2013
Long-term outcomes of drug-coated balloons in patients with diffuse coronary lesions
10.3389/fcvm.2022.935263 · 2022
Prognostic implications of quantitative flow ratio-derived physiological 2-dimensional residual disease patterns after stenting
10.1016/j.jcin.2022.06.021 · 2022
Prognostic implications of prestent pullback pressure gradient and poststent quantitative flow ratio in patients undergoing percutaneous coronary intervention
10.1161/jaha.121.024903 · 2022
Validation of virtual fractional flow reserve pullback curves
2024
No additional external references are available.